I'm still checking if my foundation shade is still the same because I'm always at home but for the record, my legs are really whiter now
Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)
We provide funding for innovative student startups If you are a student of the University of Twente or Saxion and plan on building your company in Overijssel, Dutch Student Investment Fund is your launching pad
Dual and triple agonists Dual agonists with effects on GLP-1 receptors and glucose-dependent insulinotropic polypeptide receptors, like tirzepatide, and triple agonists with effects on GLP-1, glucose-dependent insulinotropic polypeptide, and glucagon receptors like retatrutide are currently being researched for their beneficial effects on obesity and diabetes in the adult population
Advanced UV Filters: Modern chemical filters provide high-level SPF 50 defense to shield delicate lip skin from sun-induced darkening
ADA 2026b)